NO143223C - Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinolinerInfo
- Publication number
- NO143223C NO143223C NO743528A NO743528A NO143223C NO 143223 C NO143223 C NO 143223C NO 743528 A NO743528 A NO 743528A NO 743528 A NO743528 A NO 743528A NO 143223 C NO143223 C NO 143223C
- Authority
- NO
- Norway
- Prior art keywords
- quinolines
- pyrazole
- dimethyl
- preparation
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/402,657 US4013665A (en) | 1973-10-01 | 1973-10-01 | Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO743528L NO743528L (no) | 1975-04-28 |
| NO143223B NO143223B (no) | 1980-09-22 |
| NO143223C true NO143223C (no) | 1981-01-02 |
Family
ID=23592812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743528A NO143223C (no) | 1973-10-01 | 1974-09-27 | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4013665A (no) |
| JP (1) | JPS582948B2 (no) |
| BE (1) | BE820400A (no) |
| CA (1) | CA1032538A (no) |
| CH (3) | CH621552A5 (no) |
| CY (1) | CY1087A (no) |
| DE (1) | DE2446821A1 (no) |
| DK (1) | DK516274A (no) |
| ES (1) | ES430554A1 (no) |
| FI (1) | FI57414C (no) |
| FR (1) | FR2245369B1 (no) |
| GB (1) | GB1488692A (no) |
| HK (1) | HK59380A (no) |
| KE (1) | KE3086A (no) |
| MY (1) | MY8100219A (no) |
| NL (1) | NL7412959A (no) |
| NO (1) | NO143223C (no) |
| SE (1) | SE419760B (no) |
| ZA (1) | ZA746138B (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA848968B (en) * | 1983-11-18 | 1986-06-25 | Riker Laboratories Inc | 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines |
| IL73534A (en) * | 1983-11-18 | 1990-12-23 | Riker Laboratories Inc | 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds |
| US5332734A (en) * | 1991-04-10 | 1994-07-26 | Japan Tobacco, Incorporated | Oxazinone derivative |
| US5608067A (en) * | 1993-12-09 | 1997-03-04 | Afonso; Adriano | 4-substituted pyrazoloquinoline derivatives |
| US5506236A (en) * | 1994-04-28 | 1996-04-09 | Schering Corporation | 4-substituted pyrazoloquinoline derivatives |
| US5786480A (en) * | 1994-04-28 | 1998-07-28 | Schering Corporation | 4-substituted pyrazoloquinoline derivatives |
| US5614530A (en) * | 1995-03-10 | 1997-03-25 | Sterling Winthrop Inc. | Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof |
| US6008226A (en) * | 1995-03-10 | 1999-12-28 | Sanofi-Synthelabo | Substituted N-arylmethyl and heterocylylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof |
| US5488055A (en) * | 1995-03-10 | 1996-01-30 | Sanofi Winthrop Inc. | Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof |
| US7084156B2 (en) * | 2001-11-27 | 2006-08-01 | Merck & Co., Inc. | 2-Aminoquinoline compounds |
| WO2003045920A1 (en) * | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 4-aminoquinoline compounds |
| US8080560B2 (en) * | 2004-12-17 | 2011-12-20 | 3M Innovative Properties Company | Immune response modifier formulations containing oleic acid and methods |
| US8889154B2 (en) | 2005-09-15 | 2014-11-18 | Medicis Pharmaceutical Corporation | Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation |
| WO2008010963A2 (en) * | 2006-07-18 | 2008-01-24 | 3M Innovative Properties Company | Immune response modifier formulations |
| WO2008016475A2 (en) * | 2006-07-31 | 2008-02-07 | 3M Innovative Properties Company | Immune response modifier compositions and methods |
| WO2010062559A1 (en) * | 2008-10-28 | 2010-06-03 | Schering Corporation | Substituted pyrazoloquinolines and derivatives thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1152421B (de) * | 1961-03-21 | 1963-08-08 | Bayer Ag | Verfahren zur Herstellung von 4-Hydroxy-pyrazolo[3, 4-b]chinolinen |
| DE1445719A1 (de) * | 1961-03-21 | 1969-01-09 | Bayer Ag | Verfahren zur Herstellung von 4-Chlor- oder 4-Brom-pyrazolo[3,4-]chinolinen |
| DE1186867B (de) * | 1961-05-03 | 1965-02-11 | Bayer Ag | Verfahren zur Herstellung von heterocyclischen Verbindungen |
| DE1222885B (de) * | 1962-05-25 | 1966-08-18 | Bayer Ag | Optische Aufhellungsmittel |
| US3600393A (en) * | 1969-03-03 | 1971-08-17 | Aldrich Chem Co Inc | Dialkylamino alkylamino pyrazolo (3,4b) quinolines |
| JPS4826797A (no) * | 1971-08-07 | 1973-04-09 | ||
| US3790576A (en) * | 1972-03-20 | 1974-02-05 | Parke Davis & Co | 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines |
-
1973
- 1973-10-01 US US05/402,657 patent/US4013665A/en not_active Expired - Lifetime
-
1974
- 1974-09-25 FR FR7432265A patent/FR2245369B1/fr not_active Expired
- 1974-09-26 FI FI2815/74A patent/FI57414C/fi active
- 1974-09-26 ZA ZA00746138A patent/ZA746138B/xx unknown
- 1974-09-26 BE BE148952A patent/BE820400A/xx not_active IP Right Cessation
- 1974-09-27 NO NO743528A patent/NO143223C/no unknown
- 1974-09-30 CH CH1316374A patent/CH621552A5/de not_active IP Right Cessation
- 1974-09-30 GB GB42353/74A patent/GB1488692A/en not_active Expired
- 1974-09-30 CA CA210,304A patent/CA1032538A/en not_active Expired
- 1974-09-30 SE SE7412275A patent/SE419760B/xx unknown
- 1974-09-30 ES ES430554A patent/ES430554A1/es not_active Expired
- 1974-09-30 CY CY1087A patent/CY1087A/xx unknown
- 1974-10-01 NL NL7412959A patent/NL7412959A/xx not_active Application Discontinuation
- 1974-10-01 JP JP49112386A patent/JPS582948B2/ja not_active Expired
- 1974-10-01 DE DE19742446821 patent/DE2446821A1/de not_active Ceased
- 1974-10-01 DK DK516274A patent/DK516274A/da not_active Application Discontinuation
-
1980
- 1980-01-03 CH CH1180A patent/CH619712A5/de not_active IP Right Cessation
- 1980-06-24 CH CH484580A patent/CH622793A5/de not_active IP Right Cessation
- 1980-09-27 KE KE3086A patent/KE3086A/xx unknown
- 1980-10-23 HK HK593/80A patent/HK59380A/xx unknown
-
1981
- 1981-12-30 MY MY219/81A patent/MY8100219A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2245369A1 (no) | 1975-04-25 |
| NL7412959A (nl) | 1975-04-03 |
| FR2245369B1 (no) | 1978-07-28 |
| CY1087A (en) | 1980-12-27 |
| CH621552A5 (no) | 1981-02-13 |
| FI57414C (fi) | 1980-08-11 |
| GB1488692A (en) | 1977-10-12 |
| JPS5059396A (no) | 1975-05-22 |
| NO143223B (no) | 1980-09-22 |
| US4013665A (en) | 1977-03-22 |
| KE3086A (en) | 1980-11-07 |
| ES430554A1 (es) | 1977-07-01 |
| ZA746138B (en) | 1975-10-29 |
| NO743528L (no) | 1975-04-28 |
| CH622793A5 (no) | 1981-04-30 |
| DE2446821A1 (de) | 1975-04-10 |
| BE820400A (fr) | 1975-03-26 |
| AU7379874A (en) | 1976-04-01 |
| JPS582948B2 (ja) | 1983-01-19 |
| SE419760B (sv) | 1981-08-24 |
| CA1032538A (en) | 1978-06-06 |
| CH619712A5 (no) | 1980-10-15 |
| HK59380A (en) | 1980-10-31 |
| SE7412275L (no) | 1975-04-02 |
| MY8100219A (en) | 1981-12-31 |
| FI57414B (fi) | 1980-04-30 |
| DK516274A (no) | 1975-06-30 |
| USB402657I5 (no) | 1976-04-06 |
| FI281574A (no) | 1975-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO141407C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater | |
| NO145199C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere. | |
| NO141800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
| NO143460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
| NO142304C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater | |
| NO145379C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider. | |
| NO149281C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater | |
| NO142173C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme, 1,1-diaryl-1-oksadiazolalkylaminderivater | |
| NO143223C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner | |
| NO143846C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater | |
| NO146396C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater. | |
| NO141850C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. | |
| NO145198C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3 | |
| NO142838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater | |
| NO141649C (no) | Analogifremgangsmaate for fremstilling av neuroleptisk aktive 7-fluorsubstituerte fenotiaziner | |
| NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
| NO141160C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3,4-dihydro-2(1h)-isokinolinkarboksamider | |
| FI55659C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 3-(4-substituerad-piperazin-1-ylkarbonyloxi)-2-(1,8-naftyridin-2-yl)isoindolin-1-oner | |
| NO144457C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner | |
| NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
| NO146497C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-anilino-oxazoliner | |
| NO144110C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater | |
| NO144704C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-alkyl-2-(fenoksymetyl)-5-nitro-imidazoler | |
| NO145238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater | |
| NO142669C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser |